APA (7th ed.) Citation

DA, J., JE, T., CS, W., KA, H., MK, B., BM, B., . . . A, D. (2023). TACROLIMUS FOR IMMUNOSUPPRESSION IN PATIENTS WITH NONINFECTIOUS INTERMEDIATE, POSTERIOR, OR PANUVEITIDES. Retina (Philadelphia, Pa.), 43(9), 1480. https://doi.org/10.1097/IAE.0000000000003836

Chicago Style (17th ed.) Citation

DA, Jabs, Thorne JE, Wilkins CS, Habbu KA, Berkenstock MK, Burkholder BM, Chaon BC, and Deobhakta A. "TACROLIMUS FOR IMMUNOSUPPRESSION IN PATIENTS WITH NONINFECTIOUS INTERMEDIATE, POSTERIOR, OR PANUVEITIDES." Retina (Philadelphia, Pa.) 43, no. 9 (2023): 1480. https://doi.org/10.1097/IAE.0000000000003836.

MLA (9th ed.) Citation

DA, Jabs, et al. "TACROLIMUS FOR IMMUNOSUPPRESSION IN PATIENTS WITH NONINFECTIOUS INTERMEDIATE, POSTERIOR, OR PANUVEITIDES." Retina (Philadelphia, Pa.), vol. 43, no. 9, 2023, p. 1480, https://doi.org/10.1097/IAE.0000000000003836.